Investigative Ophthalmology & Visual Science, Vol 36, 1603-1614, Copyright © 1995 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23- his mutation

DG Birch, DC Hood, S Nusinowitz and DR Pepperberg
Retina Foundation of the Southwest, Dallas, TX 75231, USA.

PURPOSE. The leading edge of the rod a-wave in normal human subjects can be fit with a computational model of the activation phase of transduction to provide parameters analogous to those obtained from individual photoreceptors. The authors extend this work to the kinetics of recovery after saturating flashes. METHODS. Electroretinograms were recorded from three patients with autosomal dominant retinitis pigmentosa and the pro-23-his rhodopsin mutation, two patients with rod monochromatism, and five normal subjects. Rod-only a-waves were obtained for a series of flashes ranging from 4.4 to 10.1 ln (1.9 to 4.4 log) scot td-sec. One set of parameters describing the activation process was derived from fits to the a-wave model. A double-flash paradigm was used to study inactivation mechanisms. The first flash was achromatic and varied in intensity (I(f)) from 6.1 to 13.9 ln (2.6 to 6.0 log) scot td-sec. The second flash was a short-wavelength probe held constant at 9.3 ln (4.0 log) scot td-sec. Cone components were elicited with a photopically matched long-wavelength stimulus and were computer subtracted. Recovery at each I(f) was followed by measuring the amplitude to the probe flash at various interstimulus intervals (ISI). The critical time (Tc) before the initiation of rod recovery was determined from the function relating relative rod amplitude to ISI. RESULTS. Recovery from activation was similar in normal subjects and in patients with rod monochromatism. Over a large range of I(f) above rod saturation, Tc increased in proportion to ln I(f). The mean slope of the function relating Tc to I(f) was 2.3 s/ln I(f) when I(f) varied between 11 and 13.9 ln scot td-sec. Patients with retinitis pigmentosa and the pro-23-his rhodopsin mutation had a decrease in the gain of activation. They also had significantly slower than normal recovery after high test flash intensities, such that the slope of the function relating Tc to ln I(f) was 12.1 seconds. CONCLUSION. Available data from other species imply that complete, transient activation of transducin (T saturation) occurs within or below the investigated range of flash intensities. Based on the slope of the delay function (delta Tc/ delta ln I(f)) above 11 ln scot td-sec, the authors hypothesize that the lifetime of activated rhodopsin (R) in normal human rods is approximately 2.3 seconds. In patients with the pro-23-his mutation, the gain of the activation mechanism is reduced and the reaction determining the delta Tc/ delta ln I(f) slope is markedly slowed. The activated species that exhibits this prolonged lifetime could be the mutant rhodopsin itself.

This article has been cited by other articles:

				D M Paskowitz, M M LaVail, and J L Duncan Light and inherited retinal degeneration Br. J. Ophthalmol., August 1, 2006; 90(8): 1060 - 1066. [Abstract] [Full Text] [PDF]

				J. A. Phipps, P. Yee, E. L. Fletcher, and A. J. Vingrys Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3187 - 3194. [Abstract] [Full Text] [PDF]

				A. Kasus-Jacobi, J. Ou, D. G. Birch, K. G. Locke, J. M. Shelton, J. A. Richardson, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, and A. O. Edwards Functional Characterization of Mouse RDH11 as a Retinol Dehydrogenase Involved in Dark Adaptation in Vivo J. Biol. Chem., May 27, 2005; 280(21): 20413 - 20420. [Abstract] [Full Text] [PDF]

				G. Karan, C. Lillo, Z. Yang, D. J. Cameron, K. G. Locke, Y. Zhao, S. Thirumalaichary, C. Li, D. G. Birch, H. R. Vollmer-Snarr, et al. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: A model for macular degeneration PNAS, March 15, 2005; 102(11): 4164 - 4169. [Abstract] [Full Text] [PDF]

				R. M. Hansen and A. B. Fulton Recovery of the Rod Photoresponse in Infants Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 764 - 768. [Abstract] [Full Text] [PDF]

				J. A. Phipps, E. L. Fletcher, and A. J. Vingrys Paired-Flash Identification of Rod and Cone Dysfunction in the Diabetic Rat Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4592 - 4600. [Abstract] [Full Text] [PDF]

				J. J. K. Derwent, D. J. Derlacki, J. R. Hetling, G. A. Fishman, D. G. Birch, S. Grover, E. M. Stone, and D. R. Pepperberg Dark Adaptation of Rod Photoreceptors in Normal Subjects, and in Patients with Stargardt Disease and an ABCA4 Mutation Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2447 - 2456. [Abstract] [Full Text] [PDF]

				E. R. Elias, R. M. Hansen, M. Irons, N. B. Quinn, and A. B. Fulton Rod Photoreceptor Responses in Children With Smith-Lemli-Opitz Syndrome Arch Ophthalmol, December 1, 2003; 121(12): 1738 - 1743. [Abstract] [Full Text] [PDF]

				R. T. Tzekov, K. G. Locke, D. C. Hood, and D. G. Birch Cone and Rod ERG Phototransduction Parameters in Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3993 - 4000. [Abstract] [Full Text] [PDF]

				M. E. Pennesi, K. A. Howes, W. Baehr, and S. M. Wu Guanylate cyclase-activating protein (GCAP) 1 rescues cone recovery kinetics in GCAP1/GCAP2 knockout mice PNAS, May 27, 2003; 100(11): 6783 - 6788. [Abstract] [Full Text] [PDF]

				A. V. Cideciyan, S. G. Jacobson, N. Gupta, S. Osawa, K. G. Locke, E. R. Weiss, A. F. Wright, D. G. Birch, and A. H. Milam Cone Deactivation Kinetics and GRK1/GRK7 Expression in Enhanced S Cone Syndrome Caused by Mutations in NR2E3 Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1268 - 1274. [Abstract] [Full Text] [PDF]

				B. G. Jeffrey, D. C. Mitchell, R. A. Gibson, and M. Neuringer n-3 Fatty Acid Deficiency Alters Recovery of the Rod Photoresponse in Rhesus Monkeys Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2806 - 2814. [Abstract] [Full Text] [PDF]

				D. G. Birch, D. C. Hood, K. G. Locke, D. R. Hoffman, and R. T. Tzekov Quantitative Electroretinogram Measures of Phototransduction in Cone and Rod Photoreceptors: Normal Aging, Progression With Disease, and Test-Retest Variability Arch Ophthalmol, August 1, 2002; 120(8): 1045 - 1051. [Abstract] [Full Text] [PDF]

				L. L. Cooper, R. M. Hansen, B. T. Darras, M. Korson, F. E. Dougherty, J. M. Shoffner, and A. B. Fulton Rod Photoreceptor Function in Children With Mitochondrial Disorders Arch Ophthalmol, August 1, 2002; 120(8): 1055 - 1062. [Abstract] [Full Text] [PDF]

				H. Yamazaki, H. Ohguro, T. Maeda, I. Maruyama, Y. Takano, T. Metoki, M. Nakazawa, H. Sawada, and M. Dezawa Preservation of Retinal Morphology and Functions in Royal College Surgeons Rat by Nilvadipine, a Ca2+ Antagonist Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 919 - 926. [Abstract] [Full Text] [PDF]

				K. T. Oh, R. G. Weleber, A. Lotery, D. M. Oh, A. M. Billingslea, and E. M. Stone Description of a New Mutation in Rhodopsin, Pro23Ala, and Comparison With Electroretinographic and Clinical Characteristics of the Pro23His Mutation Arch Ophthalmol, September 1, 2000; 118(9): 1269 - 1276. [Abstract] [Full Text] [PDF]

				R. A. Bush, L. Kononen, S. Machida, and P. A. Sieving The Effect of Calcium Channel Blocker Diltiazem on Photoreceptor Degeneration in the Rhodopsin Pro23His Rat Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2697 - 2701. [Abstract] [Full Text]

				A. V. Cideciyan, X. Zhao, L. Nielsen, S. C. Khani, S. G. Jacobson, and K. Palczewski Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man PNAS, January 6, 1998; 95(1): 328 - 333. [Abstract] [Full Text] [PDF]